Oversight and Investigations

Chairman:  Tim Murphy (PA-18)
Jurisdiction: 
Responsibility for oversight of agencies, departments, and programs related to the jurisdiction of the full committee, and for conducting investigations.

Members

Republicans

Chairman: Tim Murphy (PA)
Vice Chairman: Michael C. Burgess, M.D. (TX)
Marsha Blackburn (TN)
Phil Gingrey (GA)
Steve Scalise (LA)
Gregg Harper (MS)
Pete Olson (TX)
Cory Gardner (CO)
Morgan Griffith (VA)
Bill Johnson (OH)
Billy Long (MO)
Renee Ellmers (NC)
Joe Barton (TX)
Fred Upton (MI)

Democrats

Ranking Member: Diana DeGette (CO)
Bruce Braley (IA)
Ben Ray Lujan (NM)
Jan Schakowsky (IL)
G.K. Butterfield (NC)
Kathy Castor (FL)
Peter Welch (VT)
Paul Tonko (NY)
John Yarmuth (KY)
Gene Green (TX)
John D. Dingell (MI) (non-voting)
Henry A. Waxman (CA)

June 26, 2012 | Press Release

WASHINGTON, DC - House Energy and Commerce Committee leaders today requested the Government Accountability Office (GAO) evaluate the National Nuclear Security Administration’s (NNSA) procedures for evaluating independent contractors charged with operations and management. Full Committee Chairman Fred Upton (R-MI), Ranking Member Henry A.

>>
June 26, 2012 | Letter

Excerpt: In reports requested by this Committee on safety and security problems at Los Alamos and Lawrence Livermore National Laboratories, for example, GAO has repeatedly documented weaknesses in those sites’ performance self-assessment programs

>>
June 26, 2012 | Letter

Excerpt: We ask that you undertake a study that focuses on coordination among contractor efforts and CMS efforts to oversee these contractors to ensure that they are working efficiently and effectively while guaranteeing that beneficiaries are receiving care to which they are entitled.

>>
June 25, 2012 | Letter

Excerpt: The Committee on Energy and Commerce is investigating whether the Centers for Disease Control and Prevention (CDC) is complying with Federal safety requirements in its operation of the Emerging Infectious Diseases Laboratory, also known as CDC Building 18, a $214 million Biosafety Level 3 germ lab facility used for experiments involving anthrax, dangerous strains of influenza, the SARS

>>

Pages